|
⚲
|
| Keyboard |
| Auberton-Herve Andre-Jacques
✚
|
|
|---|---|
| CIK # | 0001730329 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001730329] | |
| 4 | [0001730329] | |
| SC 13D | [0001730329] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Auberton-Herve Andre-Jacques | Bionik Laboratories Corp | [2018-05-29] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mobix Labs Inc | |
| Auberton-Herve Andre-Jacques | |
| Bionik Laboratories Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mobix Labs Inc MOBX
Make-Whole Shares (right to acquire) · derivative
|
2023-12-21 | Grant | 145,335 | ||
|
Mobix Labs Inc MOBX
Class A Common Stock
|
2023-12-21 | Grant | 145,335 | $10.00 | 1,453,350 |
|
Mobix Labs Inc MOBX
Class A Common Stock
|
2023-12-21 | Grant | 198,049 | ||
|
Bionik Laboratories Corp BNKL
Common Stock
|
2023-06-13 | Conversion | 186,111 | $0.60 | 111,667 |
|
Bionik Laboratories Corp BNKL
Convertible Promissory Note · derivative
|
2023-06-13 | Buy | 1 | $220,000.00 | 220,000 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2023-06-09 | Buy | 650,000 | $0.60 | 390,000 |
|
Mobix Labs Inc CLAY
Ordinary Shares
|
2022-02-24 | Disposed to issuer | 4,174 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2021-07-15 | Option exercise | 51,878 | $3.60 | 186,761 |
|
Bionik Laboratories Corp BNKL
Stock Option (right to buy) · derivative
|
2021-07-15 | Option exercise | 7,500 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Stock Option (right to buy) · derivative
|
2021-07-15 | Option exercise | 51,878 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2021-07-15 | Option exercise | 7,500 | $3.16 | 23,700 |
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2021-03-26 | Buy | 95,149 | ||
|
Bionik Laboratories Corp BNKL
Employee Stock Option (right to buy) · derivative
|
2019-07-26 | Grant | 115,759 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Employee Stock Option (right to buy) · derivative
|
2019-05-31 | Grant | 7,500 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2019-03-28 | Conversion | 81,492 | $3.89 | 317,004 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-07-24 | Conversion | 6,688,480 | $0.05 | 334,424 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-06-13 | Conversion | 1,040,152 | $0.06 | 62,409 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-06-13 | Conversion | 1,039,115 | $0.06 | 62,347 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-03-31 | Conversion | 12,114,710 | $0.06 | 726,883 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-03-31 | Conversion | 564,726 | $0.06 | 33,884 |
| showing 20 of 21 most recent transactions | |||||